Delek US Holdings, Inc. (DK)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 5/9.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of Delek US Holdings reveal a significant divergence between operational efficiency and shareholder returns, characterized by negative equity generation despite robust asset utilization. While the DuPont decomposition indicates strong leverage with an Equity Multiplier of 12.51x driving turnover at 1.57x, this financial engineering is undermined by a negligible net margin of -0.2%, resulting in a negative ROE of -4.2%. Although the company maintains a moderately healthy Piotroski F-Score of 5/9 and a low Beneish M-Score of -3.38 suggesting limited earnings manipulation risk, the core profitability engine is stalled by declining fundamentals; revenue contracted by 9.5% year-over-year while operating margins turned negative. This structural weakness contrasts sharply with the company's ROIC of 7.0%, which remains positive but insufficient to cover its cost of capital given the current leverage profile and margin compression.
Valuation metrics present a stark disconnect between market pricing and intrinsic value generation, particularly when viewed through a sectoral lens. The stock trades at an implied multiple significantly below the sector average P/E of 30.8x, ostensibly reflecting the distressed earnings environment rather than deep undervaluation of future cash flows. Since reported net income is negative due to the -0.2% margin and revenue contraction, traditional forward-looking DCF models become highly sensitive to assumptions regarding margin stabilization and growth reversion; any failure for margins to expand quickly could justify a multiple expansion that lags behind sector peers, while persistent weakness would further depress valuation multiples as risk premiums widen. The market appears to be pricing in continued operational headwinds rather than anticipating an imminent turnaround based on current financial statements.
Risk assessment highlights potential downside pressure exacerbated by insider behavior and deteriorating top-line momentum. Over the last 90 days, insiders have executed net selling totaling $13,340,430, a signal that often precedes further price depreciation if management lacks confidence in near-term recovery prospects. Combined with the -9.5% revenue decline and negative leverage-adjusted returns on equity, these factors suggest elevated volatility risk typical of cyclical energy plays during downturns. The data points to a scenario where downside protection is limited by insider distribution activity, while upside potential remains contingent on an unproven reversion in gross margins and asset turnover efficiency.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XOP or VDE, the fund manager is mechanically forced to buy or sell DK shares regardless of Delek US Holdings, Inc.'s individual fundamentals. We estimate $138M of passive capital is structurally linked to DK through 4 tracked ETFs. Passive flows have a limited but growing influence on DK's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 4 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Delek US Holdings, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.
If Delek US Holdings, Inc. (DK) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Exxon Mobil Corp. (XOM) as the most exposed collateral stock, sharing 2 ETFs with DK. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 4 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
DK Ownership Dynamics
ETFs with Highest DK Exposure
Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
DK Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for Delek US Holdings, Inc. over the past year sits near $30.57 (9% of 252-day volume). The current price of $52.61 trades 72.1% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
DK Capital Efficiency
How efficiently does Delek US Holdings, Inc. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Delek US Holdings, Inc. converts -1% of its EBITDA into free cash flow, negative FCF conversion — the company is consuming cash faster than it generates EBITDA, which is unsustainable long-term. The 101% reinvestment rate signals aggressive capacity expansion.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-06-10 | 1,340 | $46.55 | $62,377 |
| 2026-06-02 | 24 | $45.96 | $1,103.04 |
| 2026-05-26 | 82 | $43.68 | $3,581.76 |
| 2026-05-21 | 4 | $44.59 | $178.36 |
| 2026-05-18 | 300 | $44.81 | $13,443 |
| 2026-05-14 | 32 | $43.88 | $1,404.16 |
| 2026-05-13 | 16,504 | $46.08 | $760,504.32 |
| 2026-05-12 | 356 | $46.82 | $16,667.92 |
| 2026-05-07 | 836 | $45.00 | $37,620 |
| 2026-05-05 | 4,958 | $48.04 | $238,182.32 |
| 2026-05-01 | 26,154 | $46.59 | $1.2M |
| 2026-04-30 | 25,490 | $46.67 | $1.2M |
| 2026-04-29 | 27 | $41.04 | $1,108.08 |
| 2026-04-23 | 64 | $39.43 | $2,523.52 |
| 2026-04-21 | 150 | $38.00 | $5,700 |
| 2026-04-20 | 300 | $37.23 | $11,169 |
| 2026-04-17 | 910 | $42.45 | $38,629.5 |
| 2026-04-16 | 191 | $40.92 | $7,815.72 |
| 2026-04-15 | 216 | $39.35 | $8,499.6 |
| 2026-04-10 | 540 | $41.11 | $22,199.4 |
| 2026-04-09 | 139 | $42.74 | $5,940.86 |
| 2026-04-08 | 4,968 | $44.65 | $221,821.2 |
| 2026-04-06 | 1,331 | $45.02 | $59,921.62 |
| 2026-04-02 | 153 | $44.39 | $6,791.67 |
| 2026-04-01 | 8 | $45.07 | $360.56 |
| 2026-03-27 | 598 | $46.41 | $27,753.18 |
| 2026-03-24 | 53 | $42.39 | $2,246.67 |
| 2026-03-20 | 138 | $44.60 | $6,154.8 |
| 2026-03-18 | 14 | $42.34 | $592.76 |
| 2026-03-13 | 89 | $41.96 | $3,734.44 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare DK to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-07-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.